Dr Jane Hirst
Dr Jane Hirst is an Australian consultant obstetrician based at the University of Oxford, UK. She leads the diabetes in pregnancy service at the John Radcliffe Hospital, Oxford, a large referral hospital in England. She is also an active clinical researcher with projects focussed on global perinatal health and investigating novel approaches to improve health care delivery. She has a particular interest in gestational diabetes mellitus (GDM), preterm birth and stillbirth.
Her PhD investigated the prevalence and perinatal outcomes associated with GDM in Ho Chi Minh City and Asia, considering the effects on health systems as well as the consequences for women and their babies in resource limited settings. Since coming to Oxford she has led the team promoting the global dissemination of the findings of the INTERGROWTH-21st Study on fetal growth and development. She has jointly conducted a randomised controlled trial investigating a smart phone-based, blood glucose management system for women with GDM. In partnership with Sera Prognostics, OUCRU and the Gates Foundation, she is currently leading an observational study in Ho Chi Minh City aiming to recruit 5000 women to evaluate promising biomarkers for spontaneous preterm birth.
In 2017 she was appointed as a Senior Research Associate with the George Institute for Global Health (Oxford) and is developing a smartphone assisted decision aid to improve the care of women with diabetes in pregnancy in low resource settings. She is a Research Fellow at Green Templeton College, University of Oxford and the lead for the Athena SWAN committee within the Nuffield Department of Obstetrics & Gynaecology.